vs
Side-by-side financial comparison of GE HealthCare (GEHC) and PulteGroup (PHM). Click either name above to swap in a different company.
GE HealthCare is the larger business by last-quarter revenue ($5.7B vs $3.4B, roughly 1.7× PulteGroup). GE HealthCare runs the higher net margin — 10.3% vs 10.2%, a 0.1% gap on every dollar of revenue. On growth, GE HealthCare posted the faster year-over-year revenue change (7.1% vs -12.4%). Over the past eight quarters, GE HealthCare's revenue compounded faster (10.7% CAGR vs -13.9%).
GE Healthcare Technologies, Inc., stylized GE HealthCare, is an American health technology company based in Chicago, Illinois. It operates four divisions: Medical imaging, which includes molecular imaging, computed tomography, magnetic resonance, women’s health screening and X-ray systems; Ultrasound; Patient Care Solutions, which is focused on remote patient monitoring, anesthesia and respiratory care, diagnostic cardiology, and infant care; and Pharmaceutical Diagnostics, which manufactures...
PulteGroup, Inc. is an American residential home-construction company based in Atlanta, Georgia, United States. As of 2023, the company is the third-largest home-construction company in the United States based on the number of homes closed. In total, the company has built over 775,000 homes.
GEHC vs PHM — Head-to-Head
Income Statement — Q4 FY2025 vs Q1 FY2026
| Metric | | |
|---|---|---|
| Revenue | $5.7B | $3.4B |
| Net Profit | $588.0M | $347.0M |
| Gross Margin | 39.7% | — |
| Operating Margin | 14.5% | — |
| Net Margin | 10.3% | 10.2% |
| Revenue YoY | 7.1% | -12.4% |
| Net Profit YoY | -18.4% | -33.6% |
| EPS (diluted) | $1.28 | — |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q1 26 | — | $3.4B | ||
| Q4 25 | $5.7B | $4.6B | ||
| Q3 25 | $5.1B | $4.4B | ||
| Q2 25 | $5.0B | $4.4B | ||
| Q1 25 | $4.8B | $3.9B | ||
| Q4 24 | $5.3B | $4.9B | ||
| Q3 24 | $4.9B | $4.5B | ||
| Q2 24 | $4.8B | $4.6B |
| Q1 26 | — | $347.0M | ||
| Q4 25 | $588.0M | $501.6M | ||
| Q3 25 | $446.0M | $585.8M | ||
| Q2 25 | $486.0M | $608.5M | ||
| Q1 25 | $564.0M | $522.8M | ||
| Q4 24 | $721.0M | $913.2M | ||
| Q3 24 | $470.0M | $697.9M | ||
| Q2 24 | $428.0M | $809.1M |
| Q1 26 | — | — | ||
| Q4 25 | 39.7% | — | ||
| Q3 25 | 38.7% | 27.8% | ||
| Q2 25 | 39.6% | 28.6% | ||
| Q1 25 | 42.1% | 28.8% | ||
| Q4 24 | 42.8% | — | ||
| Q3 24 | 41.7% | 30.4% | ||
| Q2 24 | 41.4% | 31.4% |
| Q1 26 | — | — | ||
| Q4 25 | 14.5% | — | ||
| Q3 25 | 12.7% | — | ||
| Q2 25 | 13.1% | — | ||
| Q1 25 | 13.2% | — | ||
| Q4 24 | 15.1% | — | ||
| Q3 24 | 13.9% | — | ||
| Q2 24 | 12.6% | — |
| Q1 26 | — | 10.2% | ||
| Q4 25 | 10.3% | 10.9% | ||
| Q3 25 | 8.7% | 13.3% | ||
| Q2 25 | 9.7% | 13.8% | ||
| Q1 25 | 11.8% | 13.4% | ||
| Q4 24 | 13.6% | 18.6% | ||
| Q3 24 | 9.7% | 15.6% | ||
| Q2 24 | 8.8% | 17.6% |
| Q1 26 | — | — | ||
| Q4 25 | $1.28 | $2.56 | ||
| Q3 25 | $0.98 | $2.96 | ||
| Q2 25 | $1.06 | $3.03 | ||
| Q1 25 | $1.23 | $2.57 | ||
| Q4 24 | $1.58 | $4.41 | ||
| Q3 24 | $1.02 | $3.35 | ||
| Q2 24 | $0.93 | $3.83 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $4.5B | $1.8B |
| Total DebtLower is stronger | $10.0B | — |
| Stockholders' EquityBook value | $10.4B | $13.0B |
| Total Assets | $36.9B | $5.2B |
| Debt / EquityLower = less leverage | 0.96× | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $1.8B | ||
| Q4 25 | $4.5B | $2.0B | ||
| Q3 25 | $4.0B | $1.5B | ||
| Q2 25 | $3.7B | $1.2B | ||
| Q1 25 | $2.5B | $1.2B | ||
| Q4 24 | $2.9B | $1.6B | ||
| Q3 24 | $3.5B | $1.4B | ||
| Q2 24 | $2.0B | $1.4B |
| Q1 26 | — | — | ||
| Q4 25 | $10.0B | $43.9M | ||
| Q3 25 | $10.3B | — | ||
| Q2 25 | $10.3B | — | ||
| Q1 25 | $8.8B | — | ||
| Q4 24 | $9.0B | $31.1M | ||
| Q3 24 | $10.3B | — | ||
| Q2 24 | $9.2B | — |
| Q1 26 | — | $13.0B | ||
| Q4 25 | $10.4B | $13.0B | ||
| Q3 25 | $10.0B | $12.8B | ||
| Q2 25 | $9.7B | $12.6B | ||
| Q1 25 | $9.2B | $12.3B | ||
| Q4 24 | $8.4B | $12.1B | ||
| Q3 24 | $8.3B | $11.6B | ||
| Q2 24 | $7.8B | $11.2B |
| Q1 26 | — | $5.2B | ||
| Q4 25 | $36.9B | $18.0B | ||
| Q3 25 | $36.1B | $17.9B | ||
| Q2 25 | $35.5B | $17.6B | ||
| Q1 25 | $33.6B | $17.3B | ||
| Q4 24 | $33.1B | $17.4B | ||
| Q3 24 | $33.9B | $17.0B | ||
| Q2 24 | $31.9B | $16.5B |
| Q1 26 | — | — | ||
| Q4 25 | 0.96× | 0.00× | ||
| Q3 25 | 1.03× | — | ||
| Q2 25 | 1.06× | — | ||
| Q1 25 | 0.95× | — | ||
| Q4 24 | 1.06× | 0.00× | ||
| Q3 24 | 1.24× | — | ||
| Q2 24 | 1.18× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | — | $159.8M |
| Free Cash FlowOCF − Capex | — | — |
| FCF MarginFCF / Revenue | — | — |
| Capex IntensityCapex / Revenue | 2.4% | 0.7% |
| Cash ConversionOCF / Net Profit | — | 0.46× |
| TTM Free Cash FlowTrailing 4 quarters | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q1 26 | — | $159.8M | ||
| Q4 25 | — | $771.1M | ||
| Q3 25 | — | $678.4M | ||
| Q2 25 | $94.0M | $287.5M | ||
| Q1 25 | $250.0M | $134.2M | ||
| Q4 24 | — | $567.6M | ||
| Q3 24 | — | $455.9M | ||
| Q2 24 | $-119.0M | $417.5M |
| Q1 26 | — | — | ||
| Q4 25 | — | $739.8M | ||
| Q3 25 | — | $651.1M | ||
| Q2 25 | $8.0M | $253.0M | ||
| Q1 25 | $98.0M | $104.6M | ||
| Q4 24 | — | $543.1M | ||
| Q3 24 | — | $417.2M | ||
| Q2 24 | $-183.0M | $386.2M |
| Q1 26 | — | — | ||
| Q4 25 | — | 16.0% | ||
| Q3 25 | — | 14.8% | ||
| Q2 25 | 0.2% | 5.7% | ||
| Q1 25 | 2.1% | 2.7% | ||
| Q4 24 | — | 11.0% | ||
| Q3 24 | — | 9.3% | ||
| Q2 24 | -3.8% | 8.4% |
| Q1 26 | — | 0.7% | ||
| Q4 25 | 2.4% | 0.7% | ||
| Q3 25 | 2.1% | 0.6% | ||
| Q2 25 | 1.7% | 0.8% | ||
| Q1 25 | 3.2% | 0.8% | ||
| Q4 24 | 1.9% | 0.5% | ||
| Q3 24 | 1.9% | 0.9% | ||
| Q2 24 | 1.3% | 0.7% |
| Q1 26 | — | 0.46× | ||
| Q4 25 | — | 1.54× | ||
| Q3 25 | — | 1.16× | ||
| Q2 25 | 0.19× | 0.47× | ||
| Q1 25 | 0.44× | 0.26× | ||
| Q4 24 | — | 0.62× | ||
| Q3 24 | — | 0.65× | ||
| Q2 24 | -0.28× | 0.52× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
GEHC
| Imaging Segment | $2.6B | 45% |
| PCS Segment | $824.0M | 14% |
| P Dx Segment | $790.0M | 14% |
| Specialized Ultrasound Subsegment | $735.0M | 13% |
| Monitoring Solutions Subsegment | $578.0M | 10% |
| Life Support Solutions Subsegment | $247.0M | 4% |
PHM
| Home sale revenues | $3.3B | 97% |
| Financial Services | $71.7M | 2% |
| Land sale and other revenues | $29.3M | 1% |
